Whoop: Former FDA Chair Joins as Medical Chief After 'Tussle'

Whoop decided to bring a heavy-hitter from the FDA, Dr. David Shulkin, on board as their new Chief Medical Officer. This move comes after some recent friction with the federal regulator over their fitness trackers. It's a bit like asking for advice from someone who used to scold you.

David Shulkin, who once chaired a Food and Drug Administration committee, was named Whoop Inc.'s Chief Medical Officer on July 22, 2026. This appointment aims to bolster the device's medical credibility and better manage future interactions with authorities.

Whoop's screenless fitness trackers are known for monitoring sleep, recovery, and physical activity. Their accuracy has often been debated, especially with agencies like the FDA, which oversees medical devices. It's not uncommon for companies to seek figures "from the other side of the fence" in these situations.

Shulkin's arrival could be a game-changer for Whoop, particularly regarding the approval of new features or expansion into more "medical" territory. Having an ex-insider helps them speak the same language as the federal agency.

The Boston-based company Whoop recently had a "tussle" with the Food and Drug Administration. Hiring a former FDA committee chair, like Dr. Shulkin, is a clear strategy to prevent future friction and improve regulatory relationships.

For users, this means increased confidence in the scientific validity of the data collected. If a former FDA big shot puts his name on it, maybe those sleep and recovery insights are truly reliable. Or at least, that's what Whoop hopes. It's a bit like a restaurant hiring a food critic, wouldn't you say?